12/30/2024 7:07 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/16/2024 6:32 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 6:00 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 9:01 AM | Biora Therapeutics (Subject) HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/29/2024 3:43 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:37 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
10/29/2024 7:28 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:15 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:19 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:21 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024 7:24 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
|
10/23/2024 4:24 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
10/11/2024 3:52 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
10/11/2024 7:00 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/09/2024 4:40 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/16/2024 3:30 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
09/13/2024 9:37 AM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024 5:02 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
09/03/2024 3:31 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
08/23/2024 4:06 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:08 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:11 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024 4:13 PM | Biora Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/23/2024 4:03 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/21/2024 4:00 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 3:15 PM | Biora Therapeutics (Subject) DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
| Form SC 13G | |
08/14/2024 8:57 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 8:58 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
08/12/2024 3:30 PM | Biora Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024 3:15 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2024 7:05 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 8:42 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
07/08/2024 8:15 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 8:00 PM | Athyrium Funds GP Holdings LLC (Reporting) Athyrium Opportunities 2020 LP (Reporting) Athyrium Opportunities Associates Co-Invest LLC (Reporting) Athyrium Opportunities Associates III GP LLC (Reporting) Athyrium Opportunities Associates III LP (Reporting) Athyrium Opportunities III Acquisition 2 LP (Reporting) Athyrium Opportunities III Acquisition LP (Reporting) Athyrium Opportunities III Co-Invest 1 LP (Reporting) Biora Therapeutics (Issuer) Ferrell Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 7:21 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/01/2024 5:04 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
07/01/2024 5:07 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 3:30 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:31 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Howe Jill Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
A simple pattern that works in any market (Ad) Right when most traders were getting bearish, The All-Weather Pattern signaled something different.
Following this setup could've turned every $1,000 into $1,770 in just 48 hours.
But here's what really gets me excited...
You don't need to be glued to your screen all day, no complex formulas, no guessing.
Just wait for a stock to close below The All-Weather Pattern, then check if it opens higher the next morning.
That's it.
While of course I cannot promise future returns or against losses…
I've put together a complete breakdown of how this works, including the new stock that’s tending towards The All-Weather Pattern this week. If you’re interested, the complete details are all here. |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Powell Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:33 PM | Alter Jeffrey D. (Reporting) Biora Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:33 PM | Biora Therapeutics (Issuer) Kotzin Brian L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
06/02/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/24/2024 3:06 PM | Biora Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:11 PM | Biora Therapeutics (Filer)
| Form ARS | |
04/17/2024 11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/12/2024 3:30 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
04/02/2024 7:43 PM | Athyrium Opportunities 2020 LP (Filed by) Biora Therapeutics (Subject)
| Form SC 13D/A | |
04/02/2024 3:44 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 3:46 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024 3:48 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 3:45 PM | Biora Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 3:10 PM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 5:29 PM | Biora Therapeutics (Subject) Context Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
03/11/2024 7:11 AM | Biora Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 1:43 PM | ARMISTICE CAPITAL, LLC (Filed by) Biora Therapeutics (Subject)
| Form SC 13G/A | |